BNP Paribas Bonus Zert SNW 27.06..../ DE000PE5QQ28 /

2024-05-24 9:46:35 AM	Chg.0.00	Bid10:00:42 PM	Ask10:00:42 PM	Underlying	Strike price	Expiration date	Option type
89.63EUR	0.00%	- Bid Size: -	- Ask Size: -	SANOFI SA INHABER ...	- -	2024-06-27	Call

GlobeNewswire 05-23 CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

GlobeNewswire 05-21 Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration

GlobeNewswire 05-20 Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS...

GlobeNewswire 05-20 Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ...

GlobeNewswire 05-20 Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meet...

GlobeNewswire 05-13 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...

GlobeNewswire 05-13 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...

TeleTrader 05-13 Europe mixed at open as CPI prints loom

GlobeNewswire 05-13 Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...

TeleTrader 05-10 Novavax skyrockets 213.5% in premarket, highest in 16 months

TeleTrader 05-10 Novavax soars 39.6% in premarket after Sanofi license deal

GlobeNewswire 05-10 Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...

GlobeNewswire 05-09 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

TeleTrader 05-09 Europe opens mixed with BoE in focus

GlobeNewswire 05-08 IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-07 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire 05-02 Regeneron Reports First Quarter 2024 Financial and Operating Results

GlobeNewswire 05-02 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...

GlobeNewswire 04-30 Press Release: Annual General Meeting of April 30, 2024

TeleTrader 04-25 Europe opens mostly down after corporate earnings

TeleTrader 04-25 Europe down in premarket as financial results pour in

TeleTrader 04-25 Sanofi books net sales of €10.5B in Q1, up 2.4%

GlobeNewswire 04-25 Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance

GlobeNewswire 04-23 Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia

GlobeNewswire 04-17 IGM Biosciences Announces Refocusing of Sanofi Collaboration